ERBB2 and neoplasm: Gamma counting of the tibias of HER2-TTC-treated mice showed a progressive increase in the incorporated radioactivity (cpm/mg of tibia) in both non-tumor-bearing and BT-474 tumor-bearing tibias 28 and 42 days after treatment with 250 or 500 kBq/kg HER2-TTC.